InMed Pharmaceuticals Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q3 2024.
  • InMed Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 620K shares, a 273% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 7.62M shares, a 211% increase from 2023.
  • InMed Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2.45M shares, a 337% increase from 2022.
  • InMed Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 561K shares, a 109% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 620K +454K +273% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q4 2023 7.97M +5.67M +247% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 166K -699K -80.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 2.45M +1.89M +337% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 3.33M +2.76M +488% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 2.3M +1.75M +315% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 866K +384K +79.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 561K Apr 1, 2022 Jun 30, 2022 10-K 2023-09-29
Q1 2022 566K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 554K Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-17
Q3 2021 482K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.